Stocks Comparison
Airsculpt Technologies vs Oncology Institute: revenue, profit, margins and growth compared
Airsculpt Technologies brought in $151.8M of revenue in fiscal 2025, Oncology Institute $502.7M in fiscal 2025. Revenue changed by -15.8% at Airsculpt Technologies and +27.8% at Oncology Institute on the year before, so Oncology Institute grew faster. Airsculpt Technologies kept -7.7% of its revenue as net profit, Oncology Institute -12.1%. Free cash flow was $692K at Airsculpt Technologies and -$27.8M at Oncology Institute.
Side by side, latest fiscal year
| AIRS | TOI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $151.8M | $502.7M |
| Revenue growth | -15.8% | +27.8% |
| Net income | -$11.7M | -$60.6M |
| Net margin | -7.7% | -12.1% |
| Free cash flow | $692K | -$27.8M |
| Free cash flow margin | 0.5% | -5.5% |
| Earnings per share (diluted) | -$0.19 | -$0.54 |
| Cash | $8.4M | $33.6M |
| Debt | $56M | $77.4M |
| Price to earnings | n/a | n/a |
| Market value | $135.5M | $522.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #293 of 742 · Health care | #204 of 742 · Health care |
Over the years
Questions about Airsculpt Technologies and Oncology Institute
Which is bigger by revenue, Airsculpt Technologies or Oncology Institute?
Oncology Institute is bigger by revenue: $502.7M in fiscal 2025, against $151.8M for Airsculpt Technologies in fiscal 2025.
Which keeps more of its revenue as profit, Airsculpt Technologies or Oncology Institute?
Airsculpt Technologies had a net margin of -7.7% in fiscal 2025; Oncology Institute had -12.1% in fiscal 2025.
Which grew revenue faster, Airsculpt Technologies or Oncology Institute?
In their latest fiscal years revenue changed by -15.8% at Airsculpt Technologies and +27.8% at Oncology Institute.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.